Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype

This publication has 12 references indexed in Scilit:

• Occurrence of plasmidic AmpC type β-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004)
  International Journal of Antimicrobial Agents, 2006
• Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000–2004)
  Microbial Drug Resistance, 2006
• Outcomes evaluation of patients with ESBL- and non–ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program
  Diagnostic Microbiology and Infectious Disease, 2006
• Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 β-lactams: adjustments of breakpoints for strains producing extended spectrum β-lactamases
  Diagnostic Microbiology and Infectious Disease, 2005
• Emergence of KPC-Possessing Klebsiella pneumoniae in Brooklyn, New York: Epidemiology and Recommendations for Detection
  Antimicrobial Agents and Chemotherapy, 2005
• Bloodstream Infections Due to Extended-Spectrum β - Lactamase-Producing Escherichia coli and Klebsiella pneumoniae : Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy
  Antimicrobial Agents and Chemotherapy, 2004
• Determination of the In Vivo Pharmacodynamic Profile of Cefepime against Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli at Various Inocula
  Antimicrobial Agents and Chemotherapy, 2004
• Extended-Spectrum β-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type β-Lactamases
  Antimicrobial Agents and Chemotherapy, 2003
• Sustained activity and spectrum of selected extended-spectrum β-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997–2000)
  International Journal of Antimicrobial Agents, 2003
• Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory
  Journal of Clinical Microbiology, 2001